Skip to content

Successful aging in the information society- Sensory modality as a key to understanding selective attention in aging and dementia.

Successful aging in the information society- Sensory modality as a key to understanding selective attention in aging and dementia. - Selective attention in aging and dementia.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43842
Enrollment
30
Registered
2016-07-06
Start date
2018-05-15
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prodromal phase of Alzheimer's disease Alzheimer's disease

Interventions

All participants will take part in the same 3-day selective attention training program. Each session will consist of computer- based or pen and paper exercises, that involve focusing on particular t

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic): presence of at least a memory impairment, memory complaints expressed by the patient or informant, and no problems in daily life functioning - Presence of CSF biomarkers or medial temporal lobe atrophy (medial temporal lobe atrophy scale (MTA) score > 3,(Scheltens et al., 1992), indicative of an underlying AD-pathology - 60- 80 years of age - Mini Mental State Examination (MMSE) score of *23, ensuring inclusion of only mentally competent, mild MCI patients, able to understand the purpose and instructions of the study and to give informed consent

Exclusion criteria

Exclusion criteria: - Any persisting major medical conditions (for example cancer or heart disease) - Presence of psychiatric or neurological disorders (e.g.: major depression, bipolar disorder, psychotic disorders; epilepsy, multiple sclerosis or Parkinson*s Disease) - History of brain surgery, major brain trauma, or infection - Significant reductions of visual acuity (after optical correction) - Significantly reduced hearing ability (interfering with the understanding of stimuli presented during the study) - Involvement in any other cognitive or pharmaceutical intervention, aiming to improve cognition for the duration of the study

Design outcomes

Primary

MeasureTime frame
- Performance (reaction times and accuracy) on a selective attention tasks under different conditions of attention and distraction.

Secondary

MeasureTime frame
- performance on several standardized cognitive and screening tests (screening questionnaire, MMSE, memory test)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)